Cellosaurus logo
expasy logo

Cellosaurus Ff-XT28s05-ABo #14 (CVCL_C1FP)

[Text][XML][JSON]
Cell line name Ff-XT28s05-ABo #14
Accession CVCL_C1FP
Resource Identification Initiative To cite this cell line use: Ff-XT28s05-ABo #14 (RRID:CVCL_C1FP)
Comments From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
Population: Japanese.
Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_C1EB (Ff-XT28s05)
Children:
CVCL_C1FQ (Ff-XT28s05-ABo_To #14-3)CVCL_C1FR (Ff-XT28s05-ABo_To #14-4)
Sex of cell Male
Age at sampling Age unspecified
Category Induced pluripotent stem cell
Publications

PubMed=30853558; DOI=10.1016/j.stem.2019.02.005
Huai-Geng Xu, Bo Wang, Miyuki Ono, Akihiro Kagita, Kaho Fujii, Noriko Sasakawa, Tatsuki Ueda, Peter Gee, Misato Nishikawa, Masaki Nomura, Fumiyo Kitaoka ...Show all 16 authors... , Tomoko Takahashi, Keisuke Okita, Yoshinori Yoshida, Shin Kaneko, Akitsu Hotta; Show fewer authors
Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility.
Cell Stem Cell 24:566-578.e7(2019)

Patent=US20200407693
Akitsu Hotta, Huai-Geng Xu, Shin Kaneko, Bo Wang;
Method for producing low-antigenic cell.
Patent number US20200407693, 31-Dec-2020

Cross-references
Encyclopedic resources Wikidata; Q114311430
Entry history
Entry creation22-Sep-2022
Last entry update19-Dec-2024
Version number6